异基因造血干细胞移植后使用阿扎胞苷：能否只取其利而避其害？ - Suppr

Suppr

超能文献

Azacitidine after allo-SCT: the good without the bad?

作者信息

Mohty Mohamad, Chevallier Patrice

机构信息

CHU de Nantes.

出版信息

Blood. 2012 Apr 5;119(14):3199-200. doi: 10.1182/blood-2012-02-406678.

DOI:10.1182/blood-2012-02-406678

PMID:22493216

Abstract

摘要

相似文献

Azacitidine after allo-SCT: the good without the bad?

Blood. 2012 Apr 5;119(14):3199-200. doi: 10.1182/blood-2012-02-406678.

Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.

Exp Hematol. 2017 May;49:25-33. doi: 10.1016/j.exphem.2017.01.005. Epub 2017 Feb 1.

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.

Acta Haematol. 2015;134(1):40-8. doi: 10.1159/000368711. Epub 2015 Jun 6.

Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast.

Ann Hematol. 2012 Mar;91(3):367-73. doi: 10.1007/s00277-011-1321-1. Epub 2011 Sep 27.

Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft--host Disease.

Hematol Rep. 2017 Jun 15;9(2):7114. doi: 10.4081/hr.2017.7114. eCollection 2017 Jun 1.

Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT.

Eur J Haematol. 2017 Apr;98(4):348-354. doi: 10.1111/ejh.12832. Epub 2017 Feb 2.

The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1068-73. doi: 10.1016/j.bbmt.2015.03.001. Epub 2015 Mar 6.

Autologous versus allogeneic stem cell transplantation in acute myeloid leukemia.

Ann Hematol. 2004;83 Suppl 1:S134. doi: 10.1007/s00277-004-0850-2.

High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.

Leuk Res. 2017 Dec;63:22-27. doi: 10.1016/j.leukres.2017.10.010. Epub 2017 Oct 27.

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.

Bone Marrow Transplant. 2016 Sep;51(9):1184-90. doi: 10.1038/bmt.2016.102. Epub 2016 Apr 25.

引用本文的文献

Acute Myeloid Leukemia Harboring the t(16;21)(p11;q22) Translocation Treated With Venetoclax Plus Azacitidine After Cord Blood Transplantation.

Cureus. 2023 Jul 20;15(7):e42215. doi: 10.7759/cureus.42215. eCollection 2023 Jul.

Current status and prospects of hematopoietic stem cell transplantation in China.

Chin Med J (Engl). 2022 Jun 20;135(12):1394-1403. doi: 10.1097/CM9.0000000000002235.

Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives.

J Clin Med. 2022 Jan 4;11(1):253. doi: 10.3390/jcm11010253.

Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/ and early relapse after allogeneic blood stem cell transplantation: A case report.

Clin Case Rep. 2019 Sep 27;7(11):2149-2152. doi: 10.1002/ccr3.2461. eCollection 2019 Nov.

[Advances in hematopoietic stem cell transplantation for hematological disease].

Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):704-708. doi: 10.3760/cma.j.issn.0253-2727.2019.08.020.

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment.

Int J Mol Sci. 2019 Jan 8;20(1):228. doi: 10.3390/ijms20010228.

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.

Haematologica. 2016 Jul;101(7):879-83. doi: 10.3324/haematol.2015.140996. Epub 2016 Apr 14.

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial.

Biol Blood Marrow Transplant. 2016 Feb;22(2):385-390. doi: 10.1016/j.bbmt.2015.09.004. Epub 2015 Sep 9.

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Bone Marrow Transplant. 2014 Mar;49(3):389-96. doi: 10.1038/bmt.2013.204. Epub 2014 Jan 13.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Bone Marrow Transplant. 2014 Mar;49(3):361-5. doi: 10.1038/bmt.2013.186. Epub 2013 Dec 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验